J 2023

Pretreatment Cancer-Related Cognitive Impairment in Hodgkin Lymphoma Patients

JURICKOVA, Veronika, Dan FAYETTE, Juraj JONAS, Iveta FAJNEROVA, Tomas KOZAK et. al.

Základní údaje

Originální název

Pretreatment Cancer-Related Cognitive Impairment in Hodgkin Lymphoma Patients

Autoři

JURICKOVA, Veronika, Dan FAYETTE, Juraj JONAS, Iveta FAJNEROVA, Tomas KOZAK a Jiri HORACEK

Vydání

Current Oncology, Toronto, Multimed INC. 2023, 1198-0052

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30230 Other clinical medicine subjects

Stát vydavatele

Kanada

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.600 v roce 2022

Kód RIV

RIV/00216224:90249/23:00133240

Organizační jednotka

CZECRIN IV

UT WoS

001119525500001

Klíčová slova česky

kognitivní poruchy související s rakovinou; Hodgkinův lymfom; neuropsychologie; afektivní úzkost; kvalita života

Klíčová slova anglicky

cancer-related cognitive impairment; Hodgkin lymphoma; neuropsychology; affective distress; quality of life

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 11. 4. 2024 23:29, Mgr. Michal Petr

Anotace

V originále

Background: Cancer-related cognitive impairment (CRCI) is one of the most serious side effects of cancer that negatively impacts the quality of life of cancer patients and survivors. There is evidence of CRCI in Hodgkin lymphoma patients (HL); however, there is a lack of studies examining the presence of cognitive deficits before starting any treatment in HL patients. Methods: Forty adult patients (N = 40) newly diagnosed with HL (with no previous cancer diagnoses) and 40 healthy controls (N = 40) matched for age, sex, education, and premorbid intellect completed the neuropsychological battery and subjective and objective measures of affective distress and quality of life. Results: The results showed impairment in three out of six cognitive domains: verbal memory and learning, speed of processing/psychomotor speed, and abstraction/executive functions in the HL patients before the initiation of any treatment. The speed of processing/psychomotor speed domain is negatively correlated with depression. Conclusion: Cognitive deterioration in verbal memory and learning and abstraction/executive functions domains in HL patients seems to occur before the initiation of treatment independently of anxiety, depression, or physical symptoms. This suggests that HL itself may cause cognitive deficits in these cognitive domains. However, the underlying causes of CRCI still remain unclear.

Návaznosti

90249, velká výzkumná infrastruktura
Název: CZECRIN IV